Literature DB >> 9531192

Successful treatment of IgA nephropathy in association with low-grade B-cell lymphoma of the mucosa-associated lymphoid tissue type.

S K Mak1, P N Wong, K Y Lo, A K Wong.   

Abstract

Kidney and the urogenital tract are among the various mucosal sites involved in mucosa-associated lymphoid tissue (MALT) lymphoma. We report a case with simultaneous onset of crescentic immunoglobulin (Ig) A nephropathy and gastrointestinal low-grade B-cell lymphoma of the MALT type with kidney infiltration. M-component of IgM lambda was detected in the serum, and the renal biopsy specimen showed monotypic lambda light chain staining in the lymphoma cells but not the glomeruli. The heavy proteinuria and impaired creatinine clearance returned to normal, and microscopic hematuria disappeared 20 months after treatment with chlorambucil as single-agent chemotherapy. This coincided with a complete resolution of the gastric and renal lymphoma infiltration. The close association of both the onset and successful outcome of the two entities thus support their possible causal relationship, and we discuss the possibility of an association of the disturbance of the MALT by the lymphoma cells with the pathogenesis of IgA nephropathy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9531192     DOI: 10.1053/ajkd.1998.v31.pm9531192

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  11 in total

1.  How could we make a diagnosis of Wegener's granulomatosis?

Authors:  Shuang Ye; Cheng-de Yang
Journal:  Clin Rheumatol       Date:  2006-01-21       Impact factor: 2.980

2.  Profiling of autoantibodies in IgA nephropathy, an integrative antibiomics approach.

Authors:  Tara K Sigdel; Sang Hoon Woo; Hong Dai; Purvesh Khatri; Li Li; Bryan Myers; Minnie M Sarwal; Richard A Lafayette
Journal:  Clin J Am Soc Nephrol       Date:  2011-12       Impact factor: 8.237

3.  Minimal change disease associated with MALT lymphoma.

Authors:  Rahil Kasmani; Vamsee Priya Marina; Syed Abidi; Bikram Johar; Deepak Malhotra
Journal:  Int Urol Nephrol       Date:  2011-05-20       Impact factor: 2.370

4.  IgA nephropathy associated with leukemia and lymphoma: report of two cases.

Authors:  Osamu Motoyama; Yasuko Kojima; Akira Ohara; Ichirou Tsukimoto; Yukio Ishikawa; Kikuo Iitaka
Journal:  Clin Exp Nephrol       Date:  2008-01-05       Impact factor: 2.801

5.  Disseminated Gastric MALT Lymphoma with Monoclonal Gammopathy, t(11;18)(q21;q21), and Subsequent Development of T-Large Granular Lymphocytic Leukemia: A Case Report and Review of the Literature.

Authors:  Riad Akoum; Wassim Serhal; Hussein Farhat
Journal:  Case Rep Med       Date:  2015-05-06

6.  Whole-Exome Sequencing Reveals New Potential Mutations Genes for Primary Mucosa-Associated Lymphoid Tissue Lymphoma Arising From the Kidney.

Authors:  Shuang Wen; Tianqing Liu; Hongshuo Zhang; Xu Zhou; Huidan Jin; Man Sun; Zhifei Yun; Hong Luo; Ze Ni; Rui Zhao; Bo Fan
Journal:  Front Oncol       Date:  2021-01-08       Impact factor: 6.244

7.  IgA Nephropathy with Dominant IgA2 Deposition Accompanied by Mantle Cell Lymphoma.

Authors:  Kota Kakeshita; Tsutomu Koike; Teruhiko Imamura; Akinori Wada; Shiori Kobayashi; Hayato Fujioka; Hidenori Yamazaki; Koichiro Kinugawa
Journal:  Intern Med       Date:  2020-10-28       Impact factor: 1.271

8.  An unusual case of glomerulonephritis in a patient with non-Hodgkin mucosal associated lymphoid tissue (MALT) B-cell lymphoma.

Authors:  See Cheng Yeo; Khoon Leong Chuah; Hwei Yee Lee; Adrian Liew
Journal:  BMC Nephrol       Date:  2013-07-22       Impact factor: 2.388

9.  Paraneoplastic immunoglobulin A nephropathy and associated focal segmental glomerulosclerosis in asymptomatic low volume B-cell lymphoma - a case report.

Authors:  Monica Suet Ying Ng; Leo Francis; Elango Pillai; Andrew John Mallett
Journal:  BMC Nephrol       Date:  2018-09-10       Impact factor: 2.388

10.  Marginal zone lymphoma causing accelerated progression of chronic kidney disease.

Authors:  Amali Samarasinghe; Daniel Wong; Gavin Cull; Aron Chakera
Journal:  BMJ Case Rep       Date:  2019-11-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.